N6-(2-Phenylethyl)adenosine NEW
| Price | $29 | $57 | $112 |
| Package | 10mg | 25mg | 50mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: N6-(2-Phenylethyl)adenosine | CAS No.: 20125-39-7 |
| Purity: 99.94% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | N6-(2-Phenylethyl)adenosine |
| Description | N6-(2-Phenylethyl)adenosine (N6-Phenethyladenosine) is an adenosine derivative and adenosine receptor agonist with Ki values of 11.8 nM for rat A1 receptors and 30.1 nM for human A1 receptors. |
| In vitro | The Ki value of human A3 is 0.63 nM. In CHO cells, N6-(2-Phenylethyl)adenosine inhibits A2 with IC50s of 560 nM and 2250 nM for rat and human[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (26.93 mM), Solution. H2O : < 0.1 mg/mL (insoluble) 10% DMSO+90% Saline : < 10 mg/mL (26.93 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. DMSO : 255 mg/mL (686.61 mM), Sonication is recommended. |
| Keywords | P1 receptor | N6-(2-Phenylethyl)adenosine | N-6-(2-Phenylethyl)adenosine | N6(2Phenylethyl)adenosine | N6 (2 Phenylethyl)adenosine | Inhibitor | inhibit | derivative | AdenosineReceptor | Adenosine Receptor | adenosine | A3AR | A3 | A2AR | A2 | A1AR | A1 |
| Inhibitors Related | Xanthine | Theophylline monohydrate | Diphylline | Adenosine monophosphate | Acefylline | Sulcatone | Adenosine 5'-monophosphate monohydrate | Inosine | Theobromine | Adenosine 5'-monophosphate disodium salt | Theophylline | Doxofylline |
| Related Compound Libraries | Bioactive Compound Library | Neuronal Signaling Compound Library | Membrane Protein-targeted Compound Library | ReFRAME Related Library | Neurotransmitter Receptor Compound Library | Multi-Target Compound Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Compound Library | Nucleotide Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $32.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-04-22 | |
|
VIP2Y
|
Shenzhen Nexcon Pharmatechs Ltd.
|
2026-07-06 | ||
|
Anhuyan (Hainan) Biotechnology Co., LTD
|
2026-05-22 | |||
| $29.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-06-02 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY